Clinical Trial Update: Under Whole-course of Immunotherapy, Gradient Fractionated RT with CCT Versus CFRT with CCT for LANPC Who Achieved PR Post Induction Chemotherapy. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial (NCT06675214) is evaluating gradient fractionated radiotherapy with concurrent chemoradiotherapy plus immunotherapy versus conventional…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma, De-escalation Therapy | Phase 3 | Status: RECRUITING